Iterum Therapeutics announces positive pre- New Drug Application meeting with FDA for sulopenem for treatment of uncomplicated urinary tract infections

The company now plans to proceed with New Drug Application submission for sulopenem etzadroxil, a carbapenem antibiotic, combined with probenecid, in a bilayer tablet, for the treatment of uncomplicated urinary tract infections in patients with a quinolone-resistant pathogen.

Biospace Inc.